---
figid: PMC3808235__zlj9991032880001
figlink: /pmc/articles/PMC3808235/figure/F1/
number: Fig 1
caption: Pathway-guided treatment in prostate cancer. This diagram highlights pathways
  for targeting in prostate cancer, including the phosphatidylinositide 3-kinase (PI3K)
  pathway, ETS rearrangements, and androgen signaling. Green indicates putative treatment
  hypotheses for relevant pathways. Each of these pathways can be driven by genomic
  aberrations, such as point mutations, copy number alterations, and rearrangements.
  The diagram also highlights less common driving mutations involving RAS, RAF, and
  AKT oncogenes. Furthermore, there is potential for cooperation between pathways
  because these are not necessarily mutually exclusive. Genes highlighted in gold
  have known genomic alterations. AR, androgen receptor; mTOR, mammalian target of
  rapamycin, PARP, poly (ADP-ribose) polymerase; RTK, receptor tyrosine kinase.
pmcid: PMC3808235
papertitle: Advancing Precision Medicine for Prostate Cancer Through Genomics.
reftext: Sameek Roychowdhury, et al. J Clin Oncol. 2013 May 20;31(15):1866-1873.
pmc_ranked_result_index: '24830'
pathway_score: 0.9282957
filename: zlj9991032880001.jpg
figtitle: Pathway-guided treatment in prostate cancer
year: '2013'
organisms: Homo sapiens
ndex: 4d986a25-df0b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3808235__zlj9991032880001.html
  '@type': Dataset
  description: Pathway-guided treatment in prostate cancer. This diagram highlights
    pathways for targeting in prostate cancer, including the phosphatidylinositide
    3-kinase (PI3K) pathway, ETS rearrangements, and androgen signaling. Green indicates
    putative treatment hypotheses for relevant pathways. Each of these pathways can
    be driven by genomic aberrations, such as point mutations, copy number alterations,
    and rearrangements. The diagram also highlights less common driving mutations
    involving RAS, RAF, and AKT oncogenes. Furthermore, there is potential for cooperation
    between pathways because these are not necessarily mutually exclusive. Genes highlighted
    in gold have known genomic alterations. AR, androgen receptor; mTOR, mammalian
    target of rapamycin, PARP, poly (ADP-ribose) polymerase; RTK, receptor tyrosine
    kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - BRAF
  - AKT1
  - MTOR
  - MAP2K2
  - AR
  - AKT3
  - RAF1
  - PIK3R4
  - AURKA
  - KRAS
  - TIPARP
  - PARP9
  - HRAS
  - MAPK3
  - PARP2
  - PRKDC
  - MAPK1
  - ARAF
  - PIK3R3
  - ETS2
  - PIK3R6
  - PIK3R5
  - PARP14
  - PARP8
  - ETS1
  - PTEN
  - PIK3CG
  - NRAS
  - TNKS
  - PARP4
  - PIK3CB
  - MAP2K1
  - PARP3
  - PARP6
  - PARP15
  - PARP10
  - TNKS2
  - PIK3CD
  - PARP16
  - PIK3CA
  - PARP11
  - PARP12
  - PARP1
  - Androgen
  - Testosterone
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AURKA
  symbol: AURKA
  source: hgnc_symbol
  hgnc_symbol: AURKA
  entrez: '6790'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: DNAPK
  symbol: DNAPK
  source: hgnc_alias_symbol
  hgnc_symbol: PRKDC
  entrez: '5591'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: ETS
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: ETS
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
chemicals:
- word: Androgen
  source: MESH
  identifier: D000728
- word: Testosterone
  source: MESH
  identifier: D013739
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
